Dissecting the Helicobacter pylori-regulated transcriptome of B cells.


Journal

Pathogens and disease
ISSN: 2049-632X
Titre abrégé: Pathog Dis
Pays: United States
ID NLM: 101595366

Informations de publication

Date de publication:
08 10 2020
Historique:
received: 24 04 2020
accepted: 27 08 2020
pubmed: 1 9 2020
medline: 28 8 2021
entrez: 1 9 2020
Statut: ppublish

Résumé

Persistent infections with the bacterial group-I carcinogen Helicobacter pylori (H. pylori) have been associated with a broad range of gastric disorders, including gastritis, ulceration, gastric cancer or mucosa-associated lymphoid tissue (MALT) lymphoma. Pathogenesis of H. pylori requires a balance between immune tolerance and defense. Although H. pylori induces inflammatory responses, the immune system cannot eliminate the pathogen. The detailed molecular mechanisms of how H. pylori interferes with cells of the immune system, in particular infiltrated B cells, are not well investigated. Previously, it was shown that the bacterial effector and oncoprotein cytotoxin-associated gene A (CagA) is delivered into B cells followed by its tyrosine-phosphorylation. To investigate the functional consequences in B cells colonized by CagA-positive H. pylori, we analyzed the global transcriptome of H. pylori-infected Mec-1 cells by RNA sequencing. We found 889 differentially expressed genes (DEGs) and validated JUN, FOSL2, HSPA1B, SRC, CXCR3, TLR-4, TNF-α, CXCL8, CCL2, CCL4, MHC class I and MHC class II molecules by qPCR, western blot, flow cytometry and ELISA assays. The H. pylori-specific mRNA expression signature reveals a downregulation of inflammation- and migration-associated genes, whereas central signal transduction regulators of cell survival and death are upregulated.

Identifiants

pubmed: 32866262
pii: 5899724
doi: 10.1093/femspd/ftaa049
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Austrian Science Fund FWF
ID : P 29941
Pays : Austria

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of FEMS.

Auteurs

Bianca E Chichirau (BE)

Department of Biosciences, Division of Microbiology, Paris-Lodron University of Salzburg, 5020 Salzburg, Austria.

Tamara Scheidt (T)

Department of Biosciences, Bioanalytical Research Labs, Paris-Lodron University of Salzburg, 5020 Salzburg, Austria.

Sebastian Diechler (S)

Department of Biosciences, Division of Microbiology, Paris-Lodron University of Salzburg, 5020 Salzburg, Austria.

Theresa Neuper (T)

Department of Biosciences, Division of Molecular Immunology, Paris-Lodron University of Salzburg, 5020 Salzburg, Austria.

Jutta Horejs-Hoeck (J)

Department of Biosciences, Division of Molecular Immunology, Paris-Lodron University of Salzburg, 5020 Salzburg, Austria.

Christian G Huber (CG)

Department of Biosciences, Bioanalytical Research Labs, Paris-Lodron University of Salzburg, 5020 Salzburg, Austria.

Gernot Posselt (G)

Department of Biosciences, Division of Microbiology, Paris-Lodron University of Salzburg, 5020 Salzburg, Austria.

Silja Wessler (S)

Department of Biosciences, Division of Microbiology, Paris-Lodron University of Salzburg, 5020 Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH